Market research
603456.SHG Zhejiang Jiuzhou Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 13B
- P/E ratio
- 22.95
- Analyst target
- 19.7475
- Dividend yield
- Not available
- Beta
- 0.03
Community
Investor discussion
1 comment
Sign in to join the 603456.SHG discussion.
5 years, 5 months ago
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 22.8% above its 200 day moving average.
From a valuation standpoint, the stock is 37.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.2.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's total revenue rose by 47.5% to $738M since the same quarter in the previous year.
Its net income has increased by 231.4% to $110M since the same quarter in the previous year.
Finally, its free cash flow grew by 1972.4% to $282M since the same quarter in the previous year.
Based on the above factors, Zhejiang Jiuzhou Pharmaceutical Co., Ltd gets an overall score of 4/5.